Related Experiment Video
Updated: Mar 19, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma
Ina Hornemann Borg1, Mette Dahl Bendtsen1,2, Martin Bøgsted1,3
1a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.
Insights
Venous thromboembolism (VTE) affects 11% of diffuse large B-cell lymphoma (DLBCL) patients. Prior VTE, performance status, and disease stage are key risk factors for VTE in DLBCL.
Area of Science:
- Hematology
- Oncology
- Clinical Research
Background:
- Venous thromboembolism (VTE) is a significant complication in patients diagnosed with diffuse large B-cell lymphoma (DLBCL).
- Understanding VTE risk factors and diagnostic accuracy is crucial for managing DLBCL patients.
Purpose of the Study:
- To evaluate the incidence of VTE in a cohort of DLBCL patients.
- To identify risk factors associated with VTE development in DLBCL.
- To assess the quality of VTE discharge diagnoses recorded in patient registries.
Main Methods:
- Retrospective cohort study of DLBCL patients from 2007-2013 at Aalborg University Hospital.
- Medical record review to identify confirmed VTE events over two years.
- Cox regression analysis to determine VTE risk factors.
- Comparison of registry diagnoses with medical records for data quality assessment.
Main Results:
- Eleven percent of DLBCL patients were diagnosed with VTE.
- Significant associations found between VTE and prior VTE, performance status, and Ann Arbor stage.
- The positive predictive value for VTE discharge diagnosis was 85%, with a sensitivity of 53%.
Conclusions:
- VTE is a common complication in DLBCL patients, influenced by disease stage and patient factors.
- While registry diagnoses have a high positive predictive value, their sensitivity is limited, highlighting potential underdiagnosis.
- Improved diagnostic strategies and risk stratification are needed for VTE in DLBCL.
Abstract:
Venous thromboembolism (VTE) in patients with diffuse large B-cell lymphoma (DLBCL) is an important complication. We aimed to asses the risk of VTE and the quality of VTE discharge diagnosis in a cohort of DLBCL patients. Objective confirmed VTE events during two years of follow-up were identified by the review of medical records of consecutive patients with DLBCL at Aalborg University Hospital from 2007 until 2013. Information on baseline disease stage, lifestyle factors, and anticoagulant therapy were registered. Cox regression was used to assess VTE risk factors. The data quality on VTE discharge diagnosis was evaluated by comparing data on VTE discharge diagnosis from the Danish National Registry of Patients with information from the medical records. Eleven percent of patients were diagnosed with VTE. Prior VTE, performance status, and Ann Arbor stage were associated with VTE. The positive predictive value of a VTE discharge diagnosis was 85% and the sensitivity 53%.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

